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OBJECTIVES We sought to demonstrate the prevalence, incidence and prognostic value of the Brugada-
type electrocardiogram (ECG) in a general population.
BACKGROUND The Brugada syndrome is characterized by evidence of right bundle branch block and ST
segment elevation in the right precordial leads, as well as sudden death caused by ventricular
fibrillation. However, the natural history of the Brugada-type ECG remains unclear.
METHODS We investigated 4,788 subjects (1,956 men and 2,832 women) who were ,50 years old in
1958 and had undergone biennial health examinations, including electrocardiography,
through 1999. The Brugada-type ECG was defined as a terminal r9 wave in lead V1 and ST
segment elevation $0.1 mV in leads V1 and V2. Unexpected death was defined as sudden
death or unexplained accidental death.
RESULTS There were a total of 32 Brugada-type ECG cases; the prevalence and incidence were 146.2
in 100,000 persons and 14.2 persons per 100,000 person-years, respectively. The incidence
was nine times higher among men than women, and the average age at presentation was 45 6
10.5 years. The Brugada-type ECG appeared intermittently in most cases and was found in
26% of subjects who died unexpectedly. Cox survival analysis revealed that mortality from
unexpected death was significantly higher in subjects with a Brugada-type ECG than in
control subjects (p , 0.01). Unexpected deaths were more frequent among subjects with the
Brugada-type ECG who had a history of syncope (p , 0.05).
CONCLUSIONS The Brugada-type ECG is not a very rare condition in the adult Japanese population. Subjects
with a Brugada-type ECG have an increased risk of unexpected death. (J Am Coll Cardiol
2001;38:765–70) © 2001 by the American College of Cardiology
Ventricular fibrillation (VF) without obvious cardiac pathol-
ogy (i.e., idiopathic VF) accounts for 1% to 9% of survivors
of out-of-hospital cardiac arrest (1). In 1992, Brugada and
Brugada (2) reported eight patients with idiopathic VF, now
known as Brugada syndrome, which is characterized by an
electrocardiogram (ECG) showing evidence of right bundle
branch block and ST segment elevation in the right precor-
dial leads. This ECG pattern, also called the Brugada-type
ECG, was once considered a probable normal variant (3).
Since the Brugadas’ report (2), however, attention has been
directed to the relationship between the Brugada-type ECG
and sudden death. Nevertheless, epidemiologic information
on the Brugada-type ECG is scarce.
The present study, based on a 40-year follow-up of 4,788
subjects in Nagasaki, Japan, was carried out to investigate
the natural history of the Brugada-type ECG, including its
prevalence, incidence and long-term prognostic value in the
general population.
METHODS
General procedure. A total of 7,564 subjects (3,374 men
and 4,190 women) have received biennial examinations in
Nagasaki since 1958, as part of a follow-up program of
the Radiation Effects Research Foundation. A detailed
description of the program has been published elsewhere
(4,5). Of those subjects, we investigated 4,788 (1,956 men
and 2,832 women) who were ,50 years old in 1958. At
each examination, the subjects were interviewed for symp-
toms, including chest pain or syncope. Physical examination
was performed and blood pressure was measured with the
subject in the sitting position. They underwent standard
12-lead electrocardiography and chest radiography. Data
from 1958 to 1959 (the first examination) through 1998 to
1999 (the 21st examination) were analyzed in the present
study.
Definition of the Brugada-type ECG. We characterized
an ECG as the Brugada type if it showed the following: 1) a
terminal r9 wave in lead V1, characterizing right bundle
branch block; 2) a convex curve or “coved”-type ST segment
elevation $0.1 mV in lead V1 or in leads V1 and V2; and
3) “saddle-shaped”-type ST segment elevation $0.1 mV in
lead V2 or V3, or both (Fig. 1). An ECG was not
characterized as the Brugada type either if the ST segment
elevation in the right precordial leads showed the “saddle-
shaped” type alone in leads V1 to V3 or if the ST segment
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elevation was accompanied by reciprocal ST segment de-
pression in opposite leads (6,7).
The time course of ST segment abnormalities was clas-
sified into one of two categories: 1) a persistent course
showing permanent abnormalities; or 2) an intermittent
course showing transient normalization of the ST segment
pattern during follow-up (Fig. 2). In subjects with an
intermittent course of ECG abnormalities, the onset of the
Brugada-type ECG was defined as the first appearance of
the ECG manifestation during follow-up.
The ECG records of all study subjects were reviewed by
Dr. Matsuo, without reference to death certificate informa-
tion. Drs. Hayano and Seto reviewed those records on
which judgments had been made, and they concurred with
the judgments.
Definition of sudden death and unexplained accidental
death. We ascertained the cause of death in all deceased
subjects from the death certificates. Sudden death was
defined as out-of-hospital death occurring within 1 h of the
onset of acute symptoms. In addition, we investigated
deaths associated with accidents and extracted cases in
which the accidents were liable. We defined these cases as
unexplained accidental deaths, because VF might have been
the cause of the accidents. Finally, we defined unexpected
death as sudden death or unexplained accidental death.
Data and statistical analysis. Of the 4,788 subjects, we
extracted those who showed a Brugada-type ECG, and we
calculated prevalence at the time of the first examination, as
well as the 40-year incidence, stratified according to age.
The total incidence was adjusted using the 1985 world
population model (8).
We showed the subjects’ age at death, the interval
between the onset of symptoms and death, the place of
death, the cause of death and circumstances of the accidents
in all unexpected death cases with a Brugada-type ECG.
To test factors contributing to unexpected death in
Brugada-type ECG cases, we compared clinical character-
istics, time courses of ST segment abnormalities and 12-
lead ECG variables between the unexpected death group
and the “other” group, which included people who died of
other causes and those who were still alive. The ECG
variables, including heart rate, magnitude of ST segment
elevation in leads V1 and V2, QRS width and QT interval
corrected by Bazett’s formula, were measured when maximal
Abbreviations and Acronyms
ECG 5 electrocardiogram
VF 5 ventricular fibrillation
Figure 1. Twelve-lead electrocardiogram of a typical pattern of the Brugada type. A terminal R9 wave in lead V1, a convex curve or “coved”-type ST segment
elevation in leads V1 (0.3 mV) and V2 (0.4 mV) and “saddle-shaped”-type ST segment elevation in lead V3 (0.2 mV) can be seen during sinus rhythm.
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ST segment elevation in each case was observed during
follow-up. Continuous variables are reported as the mean
value 6 SD and were tested using the Wilcoxon rank-sum
test. Categorical data were analyzed by logistic regression
analysis.
The long-term prognoses of subjects showing the
Brugada-type ECG were studied. The cases were compared
with the control subjects with respect to: 1) mortality from
unexpected death; 2) mortality excluding unexpected death;
and 3) total mortality. We used the Cox proportional
hazards model to assess the difference between each pair.
Statistical Analysis System (SAS) procedures were used
for analysis (9). The level of significance was set at p , 0.05.
RESULTS
Prevalence and incidence of the Brugada-type ECG.
There was a total of 32 Brugada-type ECG cases (27 men
and 5 women). We could not find any evidence of structural
heart disease from the physical examination, including
blood pressure recordings, ECGs and chest X-rays. Al-
though all 4,788 subjects were ,50 years old in 1958, 529
were $50 years old at the first examination, because not all
the subjects underwent the first examination at 1958. At the
first examination, seven men had already presented with the
Brugada-type ECG, and they were referred to as the
“prevalence cases.” The prevalence of the Brugada-type
ECG was 146.2 in 100,000 persons. Incidence analysis was
based on the remaining 25 cases (20 men and 5 women)
who manifested the Brugada-type ECG during subsequent
examinations. In the 25 “incidence cases,” the average age at
presentation was 45 6 10.5 years. The incidence of the
Brugada-type ECG was 14.2 persons per 100,000 person-
years, and it was nine times higher among men than
women. Of the 28 subjects for whom we could assess the
time course of ST segment elevation, 25 (89%) showed an
intermittent course of ST segment elevation. The rate of the
frequency of the tracings showing a Brugada-type ECG
pattern in the intermittent course ranged from 13% to 70%
(mean 45%) during follow-up (Table 1).
Unexpected death cases with the Brugada-type ECG. Of
the 32 subjects with a Brugada-type ECG, 5 died suddenly
and 2 died of an unexplained accident. Two of the five
sudden death cases (Case 2 and 4) had an episode of
syncope (7 months and 15 years, respectively, before they
Figure 2. Standard electrocardiogram (ECG) leads V1 to V3 of a typical intermittent course taken from a subject with a Brugada-type ECG. From 1965,
we observed the Brugada-type ECG with “coved”-type ST segment elevation in lead V1 and “saddle-shaped”-type ST segment elevation in leads V2 and
V3. Transient normalization was observed in 1977, but the ECG reverted to the Brugada type in 1979. Maximal ST segment elevation in leads V1 to V3
developed in 1981.

















Male Female Male Female Male Female Male Female Male Female Male Female
19 164 159 0 0 0 0 429 452 0 0 0 0
20–29 434 563 1 0 230.4 0 2,407 3,173 1 0 41.5 0
30–39 593 1,244 2 0 337.3 0 7,099 11,822 7 1 98.6 8.5
40–49 491 611 3 0 611.0 0 9,425 16,764 6 2 63.7 11.9
50–59 203 195 1 0 429.6 0 10,535 17,228 5 1 47.5 5.8
60–69 68 55 0 0 0 0 7,570 12,594 1 1 13.2 7.9
70–79 3 4 0 0 0 0 2,799 4,507 0 0 0 0
80 0 1 0 0 0 0 519 731 0 0 0 0
Total 1,956 2,832 7 0 357.9 0 40,783 67,271 20 5 31.4† 3.5†
146.2‡ 14.2†‡
*Value of years in incidence study is the aggregate number of years contributed to each age category from 1958 to 1999 by all subjects remaining at risk for the Brugada-type
electrocardiogram (ECG). †Values are adjusted using the 1985 world population model. ‡Value of prevalence or incidence for both genders of the population.
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died). Of the two unexplained accidental death cases, Case
6 drove his automobile into a parked truck and Case 7 was
injured when he fell into a river just after palpitations
preceding syncope. Before their deaths, none of the seven
unexpected death cases had indicated any history of chest
pain on effort or at rest. The average age at death in the
unexpected death cases was 57.1 6 14.2 years (Table 2).
Factors associated with unexpected death. The frequency
of Brugada-type ECG cases with a history of syncope was
significantly higher in the unexpected death group than in
the “other” group. The course of ST segment elevation and
ECG variables were not significantly different between the
groups (Table 3).
Prognosis of subjects showing the Brugada-type ECG.
Of the 4,788 subjects (32 with a Brugada-type ECG and
4,756 control subjects), 1,263 (16 Brugada-type ECG cases
and 1,247 control subjects) were dead by the last follow-up.
Twenty-seven of those deaths were classified as unexpected,
15 (5 cases and 10 control subjects) as sudden and 12 (2
cases and 10 control subjects) as unexplained accidents.
Thus, Brugada-type ECG cases accounted for 26% of
subjects who died unexpectedly. When age and gender were
incorporated into the Cox proportional hazards model,
mortality from unexpected death was significantly higher in
the subjects with a Brugada-type ECG than in the control
subjects. Mortality excluding unexpected death, however,
was similar for both groups. Owing to the frequency of
unexpected death in the Brugada-type ECG cases, total
mortality was also significantly higher in the cases than in
the control subjects (Table 4).
DISCUSSION
Our population-based study of four decades revealed that
the Brugada-type ECG is not a very rare condition, and
subjects with a Brugada-type ECG have an increased risk of
unexpected death in the adult Japanese population.
Prevalence and incidence. Although several studies (10–
12) show the prevalence of the Brugada-type ECG, inci-
dence data are lacking in a general population. In the
present study, the prevalence and incidence of the Brugada-
type ECG were 146.2 in 100,000 persons and 14.2 persons
per 100,000 person-years, respectively.
Tohyou et al. (10) reported that the prevalence of the
Brugada-type ECG in Japanese men was 93.8 in 100,000
persons, which is ;36% less than it was in our study
population. The disparity may be due to the difference in
age distribution of the subjects studied. In addition, there
are no stringent diagnostic criteria for the Brugada-type












of Death Cause of Death
1 M 41 Several minutes Other Sudden Unknown
2 M 61 20 min Home Sudden Unknown
3 M 63 Several minutes Other Sudden Unknown
4 F 71 Several minutes Home Sudden Unknown
5 M 76 Several minutes Home Sudden Unknown
6 M 42 18 h Hospital Accidental Rupture of the liver
7 M 46 17 h Hospital Accidental Cerebral contusion
F 5 female; M 5 male.
Table 3. Clinical Characteristics and Electrocardiographic Variables of Subjects With a
Brugada-Type Electrocardiogram: Comparison Between the Unexpected Death Group





(n 5 25) p Value
Gender (male/female) 6/1 21/4 0.91
Age at entry (yrs) 30.2 6 7.0 32.9 6 7.5 0.31
Age at diagnosis† (yrs) 37.5 6 9.3 47.3 6 10.0 0.06
Syncope (presence/absence) 3/4 1/24 0.02
Courses of ST segment elevation
(persistent/intermittent)‡
1/5 2/20 0.61
Heart rate (beats/min) 58.3 6 4.8 62.7 6 7.4 0.14
Magnitude of ST segment elevation (mV)
Lead V1 0.14 6 0.05 0.15 6 0.05 0.94
Lead V2 0.21 6 0.07 0.23 6 0.11 0.74
QRS width (s) 0.10 6 0.01 0.09 6 0.01 0.09
Corrected QT interval (s1/2) 0.42 6 0.02 0.41 6 0.03 0.66
*Including individuals who died of other causes and those still alive. †Data are based on the 25 incidence cases: 6 in the
unexpected death group and 19 in the “other” group. ‡Data are based on the 28 subjects for whom the time course of ST segment
elevation could be assessed. Data are presented as the mean value 6 SD or number of subjects.
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ECG (13), which could also contribute to the difference in
the prevalence data.
It is important to note that the Brugada-type ECG is a
necessary, but not sufficient, criterion for the indication of
the Brugada syndrome, because several other conditions,
including myocardial infarction, arrhythmogenic right ven-
tricular dysplasia and early repolarization syndrome, can
cause ST segment elevation similar to that seen on the
Brugada-type ECG (7). However, the coved-type ST seg-
ment elevation appeared intermittently in most of our cases,
which is similar to that in patients with the Brugada
syndrome (6,7,14). Furthermore, the preponderance of
males and age distribution were similar to those in our
Brugada-type ECG cases and Brugada syndrome patients
(6,7,14).
Prognostic value. To the best of our knowledge, this is the
first report to make an associaton between the Brugada-type
ECG and its prognosis on the basis of long-term follow-up
study.
Mortality from unexpected death was significantly higher
in Brugada-type ECG cases than in control subjects. The
age of five subjects with a Brugada-type ECG who died
suddenly was relatively high, especially in two subjects who
died at age 71 years (Case 4) and 76 years (Case 5).
However, Case 4 had an episode of syncope 15 years before
she died, suggesting that her age at the onset of symptoms
may be earlier. In addition, Alings and Wilde (6) reported
that the age distribution of patients with the Brugada
syndrome ranged from 2 to 77 years, and their mean age at
the first arrhythmic event ranged from 22 to 65 years.
Unexpected deaths in this study were associated with a
history of syncope among Brugada-type ECG cases. How-
ever, a history of syncope may not be useful for predicting
sudden death, because more than half of the unexpected
deaths occurred at the first attack. The magnitude of ST
segment elevation did not distinguish the Brugada-type
ECG cases with unexpected death from the “other” cases,
and so it might not be useful. Although the augmentation of
ST segment elevation (15,16) or specific premature ventric-
ular contractions (17) just preceding episodes of VF have
been reported, ECGs just before sudden death were not
available for our study. A clustered family history of sudden
death (6), response to sodium channel blockers (16,18) and
genetic analysis (19) could aid diagnosis. Also, ECG re-
cordings in the parasternal second or third intercostal space
may be useful (20).
It is impossible to exclude the possibility of coronary
artery disease or ruptured aortic aneurysm, without autopsy
information, as causes of unexpected death in this epidemi-
ologic study. However, our results are similar to those in the
study of Omae et al. (21), who used an autopsied Japanese
population in which 25% of subjects who died within 1 h of
symptom onset were also classified as having “sudden
unexpected death syndrome,” which is now considered to be
identical to the Brugada syndrome (22,23). If the Brugada-
type ECG was not implicated in unexpected death, the
prognosis would have been the same for Brugada-type ECG
cases and control subjects. Mortality from unexpected
death, however, was significantly higher in the cases than in
control subjects, whereas total mortality excluding unex-
pected death was similar for both groups. Thus, the death
certificate bias was the same for Brugada-type ECG cases
and control subjects.
Study limitations. First, A family history of sudden death
could not be incorporated in the analysis, because such data
were not available from the limited information taken
regarding the history of cancer and age-related disease in the
family.
Second, because Brugada syndrome is believed to be a
type of idiopathic VF (24), it is important to exclude
structural heart disease. However, we could not perform
echocardiography or cardiac catheterization in our epidemi-
ologic study.
Third, because of the intermittent nature of the manifes-
tation of a Brugada-type ECG, the incidence may depend
on the frequency of ECG recordings. Thus, it is stressed
that the present study shows results based on biennial ECG
recordings. Also, the incidence in the Japanese population
may be higher, because the syndrome seems to be most
prevalent in Japan and Southeast Asia (13).
Finally, uncertainty about the cause of sudden or unex-
plained accidental death may cast a shadow on the present
results, in the absence of autopsies. To solve this problem,
we compared the risk of unexpected death between the
Brugada-type ECG cases and control subjects, under the
same conditions.
Conclusions. Long-term follow-up is useful for identify-
ing the Brugada-type ECG, which was not a very rare
condition in the adult Japanese population. The results of a
male preponderance, age distribution (peaking around the
fourth decade) and intermittent manifestation of ECG
abnormalities in our Brugada-type ECG cases were consis-
tent with the results in patients with Brugada syndrome.
Because subjects with a Brugada-type ECG have an ele-
Table 4. Age- and Gender-Standardized Mortality of 32 Subjects With a Brugada-Type












Mortality from unexpected death 7 20 52.63 22.78–127.75
Mortality excluding unexpected death 9 1227 1.40 0.37–3.11
Total mortality 16 1247 2.17 1.33–3.55
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vated risk of unexpected death, more definitive ECG
criteria will be needed to screen for Brugada syndrome.
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